1224432-16-9

Upstream product

• 1224432-13-6 2,6-diisopropylphenyl {[1-(diphenylmethyl)-4-(3-methoxyphenyl)-piperidin-4-yl]carbonyl}sulfamate 

Downstream Products

• 1224432-20-5 2,6-diisopropylphenyl {[4-(3-methoxyphenyl)-1-(4-methylpyrimidin-2-yl)piperidin-4-yl]carbonyl}sulfamate 
• 1224432-17-0 2,6-diisopropylphenyl {[4-(3-methoxyphenyl)-1-methylpiperidin-4-yl]carbonyl}sulfamate 
• 1224432-19-2 2,6-diisopropylphenyl {[1-benzoyl-4-(3-methoxyphenyl)piperidin-4-yl]carbonyl}sulfamate 
• 1224432-18-1 2,6-diisopropylphenyl {[1-acetyl-4-(3-methoxyphenyl)piperidin-4-yl]carbonyl}sulfamate 
• 1224432-21-6 2,6-diisopropylphenyl ({4-(3-methoxyphenyl)-1-[4-(trifluoromethyl)pyrimidin-2-yl]piperidin-4-yl}carbonyl)sulfamate 
• 1224432-22-7 2,6-diisopropylphenyl {[4-(3-methoxyphenyl)-1-(5-propylpyrimidin-2-yl)piperidin-4-yl]carbonyl}sulfamate 

Relevant academic research and scientific papers

A novel class of antihyperlipidemic agents with low density lipoprotein receptor up-regulation via the adaptor protein autosomal recessive hypercholesterolemia

We have previously reported compound 2 as a inhibitor of acyl-coenzyme A:cholesterol O-acyltransferase (ACAT) and up-regulator of the low density lipoprotein receptor (LDL-R) expression. In this study we focused on compound 2, a unique LDL-R up-regulator,